再生元授权减肥药物并分享肌肉保存药物的数据,而蓝鸟生物则走向私有化Regeneron Licenses Weight Loss Drug and Shares Data on Muscle Preservation Medicines as Bluebird Bio Goes Private

动脉网
Jun 04, 2025

by Mark Chiang马克·蒋Share To分享到Regeneron Pharmaceuticals has expanded its efforts in obesity treatment by licensing a weight loss drug and unveiling study data for two medicines aimed at preserving ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10